艾司氯胺酮与围术期神经认知障碍的研究进展
Progress in the Study of Esketamine and Perioperative Neurocognitive Impairment
DOI: 10.12677/ACM.2023.134814, PDF,   
作者: 李维维, 李晓霞*:重庆医科大学附属第二医院,麻醉科,重庆
关键词: 艾司氯胺酮围术期神经认知障碍氯胺酮Esketamine Perioperative Neurocognitive Impairment Ketamine
摘要: 随着社会老龄化及医学人文学的发展,围术期神经认知障碍逐渐进入人们的视野,成为围术期医学研究的焦点。围术期神经认知障碍指在术前及术后12个月内发生的所有神经认知功能障碍,其发病机制尚未完全明确。近年来艾司氯胺酮作为氯胺酮的异构体,因其较强的镇痛、镇静、抗炎及抗抑郁作用受到广泛重视。本文总结艾司氯胺酮的作用及作用机制,探讨艾司氯胺酮在围术期神经认知障碍产生影响的作用机制,以期探索合理的运用方式。
Abstract: With the aging of society and the development of medical humanities, perioperative neurocognitive impairment has gradually entered people’s vision and become the focus of perioperative medical research. Perioperative neurocognitive impairment refers to all neurocognitive impairment occur-ring before and within 12 months after surgery, and its pathogenesis is not completely clear. In re-cent years, as the isomer of ketamine, Esketamine has been widely recognized for its strong analge-sic, sedative, anti-inflammatory and antidepressant effects. This article summarizes the function and mechanism of Esketamine, and discusses the mechanism of its effect on neurocognitive im-pairment during perioperative period, with a view to exploring a reasonable way of use.
文章引用:李维维, 李晓霞. 艾司氯胺酮与围术期神经认知障碍的研究进展[J]. 临床医学进展, 2023, 13(4): 5769-5772. https://doi.org/10.12677/ACM.2023.134814

参考文献

[1] Evered, L., Silbert, B., Knopman, D.S., et al. (2018) Recommendations for the Nomenclature of Cognitive Change Asso-ciated with Anaesthesia and Surgery—2018. Anesthesiology, 129, 872-879. [Google Scholar] [CrossRef
[2] Zanos, P., Moaddel, R., Morris, P.J., et al. (2018) Ketamine and Ketamine Metabolite Pharmacology: Insights into Therapeutic Mechanisms. Pharmacological Reviews, 70, 621-660. [Google Scholar] [CrossRef
[3] Trimmel, H., Helbok, R., Staudinger, T., et al. (2018) S(+)-Ketamine: Current Trends in Emergency and Intensive Care Medicine. Wiener Klinische Wochenschrift, 130, 356-366. [Google Scholar] [CrossRef] [PubMed]
[4] 李峰, 沈通桃. 围术期非阿片类镇痛药的应用进展[J]. 系统医学, 2021, 6(2): 195-198.
[5] Sleigh, J., Harvey, M., Voss, L., et al. (2014) Ketamine—More Mechanisms of Action than Just NMDA Blockade. Trends in Anaesthesia and Critical Care, 4, 76-81.
[6] Bourgoin, A., Albanèse, J., Wereszczynski, N., et al. (2003) Safety of Sedation with Ketamine in Severe Head Injury Patients: Comparison with Sufentanil. Critical Care Medicine, 31, 711-717. [Google Scholar] [CrossRef
[7] Ardalan, M., Wegener, G., Rafati, A.H. and Nyen-gaard, J.R. (2017) S-Ketamine Rapidly Reverses Synaptic and Vascular Deficits of Hippocampus in Genetic Animal Model of Depression. International Journal of Neuropsychopharmacology, 20, 247-256. [Google Scholar] [CrossRef] [PubMed]
[8] Cavalleri, L., Merlo Pich, E., Millan, M.J., et al. (2018) Ketamine En-hances Structural Plasticity in Mouse Mesencephalic and Human iPSC-Derived Dopaminergic Neurons via AMPAR-Driven BDNF and mTOR Signaling. Molecular Psychiatry, 23, 812-823. [Google Scholar] [CrossRef] [PubMed]
[9] Ottum, P.A., Arellano, G., Reyes, L.I., Iruretagoyena, M. and Naves, R. (2015) Opposing Roles of Interferon-Gamma on Cells of the Central Nervous System in Autoimmune Neuroinflamma-tion. Frontiers in Immunology, 6, Article 539. [Google Scholar] [CrossRef] [PubMed]
[10] 尹昌浩, 郭艳芹, 韩璎. 轻度认知障碍的研究进展[J]. 医学研究生学报, 2012, 25(9): 977-980.
[11] 钱志峰, 毛发江, 徐磊, 等. 右美托咪定联合地佐辛镇痛方案对腹腔镜胆囊切除术患者的镇痛、炎性细胞因子及术后认知功能的影响探究[J]. 东南国防医药, 2017, 19(2): 187-189.
[12] Bickford, D., Morin, R.T., Catalinotto, D., Mackin, R.S. and Nelson, J.C. (2018) Screening for Execu-tive Dysfunction in Late-Life Depression: Utility of Trail Making Test and Self-Report Measures. The American Journal of Geriatric Psychiatry, 26, 1091-1094. [Google Scholar] [CrossRef] [PubMed]
[13] Maciel, M., Benedet, S.R., Lunardelli, E.B., et al. (2019) Predicting Long-Term Cognitive Dysfunction in Survivors of Critical Illness with Plasma Inflammatory Markers: A Retrospective Cohort Study. Molecular Neurobiology, 56, 763-767. [Google Scholar] [CrossRef] [PubMed]
[14] Mazarati, A., Maroso, M., Iori, V., Vezzani, A. and Carli, M. (2011) High-Mobility Group Box-1 Impairs Memory in Mice through Both Toll-Like Receptor 4 and Receptor for Ad-vanced Glycation End Products. Experimental Neurology, 232, 143-148. [Google Scholar] [CrossRef] [PubMed]
[15] Melo, A., Leite-Almeida, H., Ferreira, C., Sousa, N. and Pêgo, J.M. (2016) Exposure to Ketamine Anesthesia Affects Rat Impulsive Behavior. Frontiers in Behavioral Neuroscience, 10, Article 226. [Google Scholar] [CrossRef] [PubMed]
[16] 彭金芝, 李晓东, 王乾兴. 氯胺酮滥用致认知障碍与海马改变的研究进展[J]. 天津医药, 2021, 49(4): 444-448.
[17] 李高炜, 李军. 氯胺酮上调miR-218水平改善胃肠道手术患者术后认知功能[J]. 数理医药学杂志, 2021, 34(2): 236-238.